Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study

Authors

  • Santosh Shrestha Department of Surgery, Western Regional Hospital, Pokhara
  • DB Adhikari Department of Surgery, Western Regional Hospital, Pokhara
  • A Gurung Department of Surgery, Western Regional Hospital, Pokhara
  • S Pradhan Department of Surgery, Western Regional Hospital, Pokhara
  • NV Gurung Department of Surgery, Western Regional Hospital, Pokhara
  • A Acharya Department of Surgery, Western Regional Hospital, Pokhara
  • D Shrestha Department of Surgery, Western Regional Hospital, Pokhara
  • SR Poudel Department of Surgery, Western Regional Hospital, Pokhara
  • A Chapagain Department of Surgery, Western Regional Hospital, Pokhara
  • D Shrestha Department of Surgery, Western Regional Hospital, Pokhara
  • P Lamichhane Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok

DOI:

https://doi.org/10.3126/jgmcn.v10i1.17912

Keywords:

Alfuzosin, Alpha blocker, Ureteral stent, Urinary symptoms

Abstract

Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.

Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms.

Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed.

Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group.

Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms.

Journal of Gandaki Medical College

Vol. 10, No. 1, 2017, page: 28-30

Downloads

Download data is not yet available.
Abstract
545
PDF
597

Downloads

Published

2017-08-01

How to Cite

Shrestha, S., Adhikari, D., Gurung, A., Pradhan, S., Gurung, N., Acharya, A., Shrestha, D., Poudel, S., Chapagain, A., Shrestha, D., & Lamichhane, P. (2017). Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study. Journal of Gandaki Medical College-Nepal, 10(1), 28–30. https://doi.org/10.3126/jgmcn.v10i1.17912

Issue

Section

Original Articles